Stability of amrinone and digoxin, procainamide hydrochloride, propranolol hydrochloride, sodium bicarbonate, potassium chloride, or verapamil hydrochloride in intravenous admixtures.
The stability of amrinone and digoxin, procainamide hydrochloride, propranolol hydrochloride, sodium bicarbonate, potassium chloride, or verapamil hydrochloride in intravenous admixtures was studied. Admixtures of amrinone and digoxin were studied at one concentration. Amrinone admixtures with propranolol hydrochloride, sodium bicarbonate, potassium chloride, and verapamil hydrochloride were studied at two concentrations. In general, 0.45% sodium chloride injection was used as the diluent; 5% dextrose injection was also used for the procainamide hydrochloride experiments. Duplicate solutions of each test admixture and single-drug control admixture were prepared and stored for four hours at 22-23 degrees C under fluorescent light. Samples were analyzed by visual inspection, tested for pH, and assayed by high-performance liquid chromatography. Admixtures containing amrinone 1.25 or 2.5 mg/mL (as the lactate salt) and sodium bicarbonate 37.5 mg/mL precipitated immediately or within 10 minutes. No changes in pH or visual appearance were noted for amrinone admixtures with procainamide hydrochloride, digoxin, propranolol hydrochloride, potassium chloride, and verapamil hydrochloride. Appreciable degradation of both amrinone and procainamide was observed after four hours when the two were mixed in 5% dextrose. No degradation of amrinone or procainamide was seen when the 5% dextrose was replaced by 0.45% sodium chloride. Amrinone and sodium bicarbonate were incompatible in intravenous admixtures. Amrinone was compatible with digoxin, propranolol hydrochloride, potassium chloride, and verapamil hydrochloride. Amrinone and procainamide were compatible in 0.45% sodium chloride injection but not in 5% dextrose injection.
Riley
C M
CM
Department of Pharmaceutical Chemistry and Pharmacy Practice, University of Kansas (UK), Lawrence 66045.
Junkin
P
P
D000676:Amrinone / Q000737:chemistry*; D001639:Bicarbonates / Q000737:chemistry; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D004077:Digoxin / Q000737:chemistry*; D004338:Drug Combinations; D004344:Drug Incompatibility; D004355:Drug Stability; D011189:Potassium Chloride / Q000737:chemistry; D011342:Procainamide / Q000737:chemistry*; D011433:Propranolol / Q000737:chemistry*; D012964:Sodium / Q000737:chemistry; D017693:Sodium Bicarbonate; D014700:Verapamil / Q000737:chemistry
D001639:Bicarbonates; D004338:Drug Combinations; D011189:Potassium Chloride; D004077:Digoxin; D017693:Sodium Bicarbonate; D012964:Sodium; D011433:Propranolol; D014700:Verapamil; D000676:Amrinone; D011342:Procainamide